LabGenomics USA has successfully acquired Integrated Molecular Diagnostics (IMD) CLIA labs, bringing the total number of its CLIA-certified labs in the U.S. to four. This acquisition strengthens LabGenomics’ strategic development and expands its diagnostic services nationwide, particularly in molecular technology. In August 2023, LabGenomics acquired QDx, a pathology-specialized lab on the East Coast, which became the company’s first CLIA-certified lab and marked its entry into the U.S. With the addition of IMD, LabGenomics now operates facilities in Berkeley, Sacramento, and Aurora, broadening its geographic reach and service offerings.
Read the full article: LabGenomics USA Completes Acquisition of IMD CLIA Labs //
Source: https://www.businesswire.com/news/home/20241025511507/en/LabGenomics-USA-Completes-Acquisition-of-IMD-CLIA-Labs